During the past decade, The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" #1 sponsor was "Pfizer" with 3 trials, followed by "Agenus Inc." with 1 trials sponsored, "American Society of Clinical Oncology" with 1 trials sponsored, "Cancer Insight, LLC" with 1 trials sponsored and "Leap Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" are "Melanoma" (2 trials), "Ovarian Cancer" (2 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials) and "Angiosarcoma" (1 trials). Many other conditions were trialed in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" in a lesser frequency.

Most popular intervention types in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Atezolizumab and PHESGO" (1 trials), "Atezolizumab and Talazoparib" (1 trials), "Balstilimab" (1 trials) and "Botensilimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate" are 7 trials for "All" genders.

Currently, there are NaN active trials in "The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".